Previous Article | Next Article ![]()
Infection and Immunity, January 2009, p. 341-347, Vol. 77, No. 1
0019-9567/09/$08.00+0 doi:10.1128/IAI.01097-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.

Center for Infectious Disease Research and Vaccinology, South Dakota State University, Brookings, South Dakota
Received 2 September 2008/ Returned for modification 6 October 2008/ Accepted 13 October 2008
|
|
|---|
|
|
|---|
Bacterial pathogens often induce host cell apoptosis to promote their survival and dissemination (16, 30). While several E. coli serotypes (1, 4, 9, 15) and toxins (3, 19) have been shown to induce apoptosis of epithelial cells, the extent to which ETEC damages host cells is unclear. The prototypic ETEC isolate H10407 was cytotoxic to but failed to induce apoptosis in the macrophage cell line J774 (as measured by DNA fragmentation) (24). The extent to which LT induces apoptosis has also received considerable attention due to interest in the receptor-binding subunit (LT-B) as a mucosal adjuvant. LT-B induces apoptosis of CD8+ but not CD4+ T cells (37). Some studies indicate that binding of LT-B to GM1 may be sufficient for triggering apoptosis of CD8+ T cells (33), while others suggest that modified LT-B constructs (e.g., H57S) still able to bind GM-1 may fail to trigger apoptosis (14). Yet other studies suggest that LT-mediated apoptosis requires the ADP-ribosylation activity of the LT-A subunit (41).
Overall, the roles of ETEC and LT in mediating apoptosis have not been defined clearly and remain somewhat controversial. The goals of this study were therefore to quantify the ability of ETEC to damage porcine intestinal epithelial cells, to clarify the role of LT in these processes, and to measure any resultant increases in ETEC adherence.
|
|
|---|
Bacterial strains. Bacterial plasmids and strains used in this study are described in Table 1.
|
View this table: [in a new window] |
TABLE 1. Bacterial strains used in this study
|
Purification of LT. LT was extracted from E. coli C600, a derivative of E. coli K-12 containing the EWD299 plasmid (6), and purified by one-step chromatography with an immobilized D-galactose column, using the protocol described by Uesaka et al. (43).
Purification of OMVs. Outer membrane vesicles (OMVs) were harvested from culture supernatants of bacteria grown overnight in 50 ml LB at 37°C with shaking (150 rpm) according to the method of Kesty et al. (21). Bacteria were pelleted by centrifugation (10,000 x g, 10 min, 4°C), and the supernatant was decanted and passed through a 0.2-µm filter. OMVs were collected by ultracentrifugation (150,000 x g, 3 h, 4°C) and resuspended to 1.0 mg/ml in water.
Quantification of IPEC-J2 PS exposure.
Exposure of phosphatidylserine (PS) on the outer leaflet of IPEC-J2 cells was quantified by staining with Alexa fluor 488-annexin V, using a Vybrant apoptosis assay kit as described by the manufacturer (Invitrogen). Propidium iodide (PI) uptake was quantified as a measure of cell death. Where indicated, cells were infected for 4 h with ETEC (multiplicity of infection [MOI],
10) or treated with 100 ng/ml LT, 1 µg/ml OMVs (21), or 100 µM camptothecin (7), with or without 100 µM Ac-DEVD-CHO (39). For all flow cytometric analyses, 20,000 events were collected and analyzed with a FACScan flow cytometer (Becton Dickinson).
Quantification of IPEC-J2 esterase activity. Intracellular esterase activity was quantified by staining cells with calcein-acetoxymethyl ester (calcein-AM) and measuring the resultant conversion to fluorescent calcein, using a Live/Dead viability/cytotoxicity kit as described by the manufacturer (Invitrogen). Where indicated, cells were treated with 100 µg/ml gentamicin to remove extracellular bacteria.
Quantification of IPEC-J2 DNA fragmentation. DNA fragmentation resulting from ETEC infection was quantified by terminal deoxynucleotidyltransferase-mediated dUTP-biotin nick end labeling (TUNEL) staining, using an in situ cell death detection kit as described by the manufacturer (Roche), at different time intervals for up to 24 h postinfection.
Immunoblot analyses.
IPEC-J2 cells were seeded in six-well plates (
3.0 x 105 cells/well) and infected with the indicated ETEC strains at an MOI of
10 for 4 h. After infection, cells were washed with phosphate-buffered saline (PBS), scraped into 1 ml PBS, pelleted by centrifugation (8,000 x g, 2 min, 4°C), and lysed in 1% sodium dodecyl sulfate, 10% glycerol, 10% β-mercaptoethanol, 0.01% bromophenol blue, 50 mM Tris, pH 6.8. Equivalent amounts of proteins were resolved through sodium dodecyl sulfate-12% polyacrylamide gels, transferred to nitrocellulose, blocked for 1 h in Odyssey blocking buffer (Li-Cor Biosciences), and incubated overnight with a rabbit anti-active-caspase-3 primary antibody (1:1,000; BD Biosciences). Secondary anti-rabbit IRDye 680 was used at a 1:15,000 dilution in Odyssey blocking buffer containing 0.2% Tween 20 (vol/vol) (Li-Cor) for 30 min at room temperature. After washing of the samples in PBS, images were obtained using an Odyssey infrared imaging system (Li-Cor).
CAT assays. Chloramphenicol acetyltransferase (CAT) assays were performed as described previously (38), using ETEC 2534-86 grown to an optical density at 600 nm of 0.4 to 0.6 in CFA medium (1% Casamino Acids, pH 7.4, 0.08% yeast extract, 0.4 mM MgSO4, 0.04 mM MnCl2), supplemented where indicated with cell-free supernatants (3% [vol/vol]) derived from donor cells treated with 100 µM camptothecin, with or without 100 µM Ac-DEVD-CHO, for 1 h.
Quantitative bacterial adherence assays.
IPEC-J2 cells were seeded in 24-well plates (
1.0 x 104 cells/well), grown overnight, and infected with
1.0 x 105 CFU/well (MOI,
10). After 4 h of incubation, samples were processed for enumeration of adherent bacteria by being washed extensively with PBS and treated with 0.25% trypsin (5 min, 37°C). Trypsinized cells and adherent ETEC were centrifuged (1,000 x g, 5 min), resuspended in 1 ml PBS, serially diluted, plated on LB, and incubated overnight at 37°C. The number of CFU was measured, and data were normalized to the CFU/ml of the bacterial inoculum. Where indicated, cells were treated with 100 µM camptothecin, with or without 100 µM Ac-DEVD-CHO, for 1 h prior to ETEC infection.
For experiments involving pretreatment of ETEC prior to adherence assays, bacteria were grown overnight, subcultured 1:20, and grown for 2 h in the presence of filtered cell supernatants obtained from cells treated with 100 µM camptothecin, with or without 100 µM Ac-DEVD-CHO. Naïve cells were then infected for 4 h with
1.0 x 105 CFU/well.
Statistical methods. Experiments were performed in duplicate on at least three separate occasions. Flow cytometry data are presented as means ± standard deviations (SD) and were analyzed with unpaired Student's t tests. Bacterial adherence assays were analyzed by calculating the median number of CFU in each treatment group and were compared with the Mann-Whitney test to determine significant differences among treatments. P values of <0.05 were considered significant.
|
|
|---|
eltAB (the
eltAB strain), an isogenic mutant deficient in LT expression, and a mutant complemented by plasmid-based eltAB expression (the
eltAB/pLT strain) also increased PS exposure to similar magnitudes (20.2% ± 2.2% and 25.1% ± 4.2%; P = 0.05 and 0.04, respectively). In contrast, infection with G58-1, an E. coli strain originally isolated from swine feces that lacks any known plasmids, produces no known enterotoxins (12), and is considered to be a commensal strain (5), did not significantly alter PS exposure (4.3% ± 1.2%; P = 0.58). Administration of 100 ng/ml LT only modestly increased PS exposure relative to that in untreated cells (11.8% ± 2.0%; P = 0.20) (Fig. 1B).
![]() View larger version (20K): [in a new window] |
FIG. 1. ETEC induces PS exposure in IPEC-J2 cells. (A) Flow cytometry analysis of PI (y axis) versus annexin V (x axis) staining of IPEC-J2 cells following infection (4 h) with the bacterial strains G58-1, wt 2534-86, 2534-86 eltAB, and 2534-86 eltAB/pLT or intoxication with 100 ng/ml LT. (B) Quantification (% positive cells) (means ± SD; n = 4) of annexin V (open bars) and PI (shaded bars) staining from flow cytometry experiments. (C) Quantification (means ± SD; n = 4) of annexin V (open bars) and PI (shaded bars) staining as a function of time (1 to 4 h) following inoculation of IPEC-J2 cells with wt 2534-86. (D) Quantification (means ± SD; n = 4) of annexin V (open bars) and PI (shaded bars) staining following intoxication of IPEC-J2 cells (4 h) with OMVs (100 ng/ml) purified from the indicated bacterial strains.
|
eltAB and
eltAB/pLT strains also modestly increased cell death. To determine the time course over which PS exposure occurred during ETEC infection, we quantified annexin V and PI staining as a function of time following inoculation with wt 2534-86. The percentage of IPEC-J2 cells that stained positive for annexin V increased as a function of time, from 6.6% ± 1.4% (1 h) to 23.4% ± 2.3% (4 h). The extent of PI staining was not significantly different as a function of time (Fig. 1C).
To determine if PS exposure was due to a secreted factor versus dependent upon ETEC binding to host cells, we intoxicated host cells with OMVs purified from ETEC possessing or lacking LT. LT is highly enriched in OMVs when ETEC is grown to high density in liquid culture (18). Incubation of IPEC-J2 cells with 1.0 µg/ml OMVs purified from 2534-86 significantly increased PS exposure, irrespective of the presence of LT (19% to 23%; P = 0.03) (Fig. 1D). Neither purified LT (Fig. 1B) (P = 0.17) nor OMVs (Fig. 1D) (P = 0.09) significantly increased cell death. These data suggest that porcine ETEC induces alterations in intestinal epithelial cell membrane structure commonly associated with apoptosis (8) and further suggest that LT is unlikely the primary determinant of this activity.
ETEC inhibits host calcein-AM degradation. We next sought to determine if ETEC might also alter the metabolic activity of infected cells. We therefore quantified host calcein fluorescence following ETEC infection and subsequent incubation with calcein-AM, a nonfluorescent lipophilic ester that penetrates cellular membranes. Rapid degradation of calcein-AM by cytosolic esterases generates calcein, a fluorescent, non-membrane-permeative molecule (42). Quantification of calcein fluorescence following calcein-AM uptake therefore provides a convenient assay of cell viability and metabolic activity (11).
ETEC infection, irrespective of eltAB expression, significantly inhibited the conversion of calcein-AM to fluorescent calcein compared to that in uninfected cells (80.9% versus 2.2%; P = 0.004) (Fig. 2A, lower left quadrants). We observed a particularly intriguing phenotype, as a large percentage of infected cells failed to stain with PI yet had only limited calcein fluorescence (Fig. 2A). We gated these cells to quantify calcein fluorescence in live (able to exclude PI) cells. Only 4.4% ± 1.1% of live, uninfected cells failed to exhibit intense green fluorescence, whereas 62.0% ± 3.8% of cells infected with the wt strain were markedly reduced in calcein fluorescence (Fig. 2B) (P = 0.001), suggesting a loss of cell viability and/or esterase activity. Infection with both the
eltAB (P = 0.003) and
eltAB/pLT (P = 0.01) strains also significantly inhibited calcein fluorescence. Neither intoxication with LT (Fig. 2B) or guanylin, an agonist of the guanylyl cyclase C (GC-C) receptor targeted by ST (10; data not shown), nor infection with G58-1 or heat-killed ETEC significantly altered calcein fluorescence (Fig. 2B). To determine the time course over which host calcein fluorescence was diminished as a result of ETEC infection, we quantified calcein fluorescence as a function of time following inoculation with wt 2534-86. The percentage of calcein-negative cells increased from 4.2% ± 0.8% to 62.0% ± 3.8% from 1 to 4 h postinoculation (Fig. 2C). In contrast to the ability of OMVs to induce PS exposure, incubation of IPEC-J2 cells with OMVs purified from ETEC possessing or lacking LT did not alter calcein fluorescence (Fig. 2D).
![]() View larger version (21K): [in a new window] |
FIG. 2. ETEC infection inhibits calcein-AM conversion in IPEC-J2 cells. (A) Flow cytometry analysis of PI staining (y axis) versus calcein fluorescence (x axis) in IPEC-J2 cells following infection with the bacterial strains G58-1, wt 2534-86, 2534-86 eltAB, and 2534-86 eltAB/pLT or intoxication with 100 ng/ml LT. (B) Quantification (means ± SD; n = 4) of the percentages of calcein-negative cells from flow cytometry experiments. (C) Quantification (means ± SD; n = 4) of the percentages of PI-positive (open bars) and calcein-negative (shaded bars) cells as a function of time (1 to 4 h) following inoculation of IPEC-J2 cells with wt 2534-86. (D) Quantification of the percentages of PI-positive (open bars) and calcein-negative (shaded bars) cells following intoxication of IPEC-J2 cells (4 h) with 100 ng/ml OMVs purified from the indicated bacterial strains. (E) Quantification of calcein fluorescence as a function of time after gentamicin treatment (0 to 60 min) of IPEC-J2 cells infected with wt 2534-86.
|
Together, these data indicate that porcine ETEC profoundly modulates the membrane asymmetry and metabolic activity of infected host cells. Notably, the observed phenotypes are unlikely to be attributable to either CD14 or the lipopolysaccharide-binding protein (40) because OMVs (rich in lipopolysaccharide) from a nonpathogenic strain (G58-1) had no measurable activity in annexin V assays. In addition, heat-killed ETEC did not alter PS exposure or calcein fluorescence.
ETEC does not induce host DNA double-strand breaks. To determine if ETEC and/or LT induces double-strand DNA breakage, which typically occurs in the late stages of apoptosis, we employed a TUNEL assay to quantify DNA strand breakage at the single-cell level (24). As shown in Table 2, no significant difference in TUNEL staining was observed as a function of ETEC infection, even at incubation times of up to 24 h postinfection, in agreement with earlier studies of ETEC H10407 infection of J774 macrophages (24), or following incubation with LT. Together, these data suggest that while ETEC may induce changes to host cells that are commonly associated with the early stages of apoptosis, subsequent signal transduction events may be inhibited at a later point in the pathway.
|
View this table: [in a new window] |
TABLE 2. ETEC does not induce DNA double-strand breaks in IPEC-J2 cells
|
![]() View larger version (14K): [in a new window] |
FIG. 3. Diversity of porcine ETEC strains in inducing host cell damage. (A) Quantification of annexin V-positive cells (y axis) (means ± SD; n = 4) following a 4-h infection with the indicated bacterial strains (x axis). (B) Quantification of calcein-negative cells (means ± SD; n = 4).
|
60% of cells were calcein negative) equivalent to that in 2534-86 (Fig. 3B). Three strains (NADC 1477, 06-7728, and 06-641) had an intermediate phenotype (
40% of cells were calcein negative), whereas the remaining four strains did not induce significant changes in host calcein fluorescence. All ETEC strains that induced significant PS exposure and reduced calcein fluorescence, except for 06-6988, display either K88ac or F41 fimbriae and efficiently bind to IPEC-J2 cells (23). The strains that failed to induce significant changes in PS exposure and host calcein fluorescence display F18 or unknown fimbria phenotypes yet still possess various enterotoxins. This observation suggests that ETEC enterotoxins do not play a significant role in mediating early apoptotic changes in these cells and that efficient adherence to host cells is required.
Host cell damage increases ETEC adherence.
To determine if host caspases are activated in response to ETEC infection, we assayed for the presence of active caspase 3 in IPEC-J2 cells following infection with ETEC or intoxication with LT. Both the wt and
eltAB strains activated host caspase 3, whereas infection with G58-1 or intoxication with LT did not (Fig. 4A).
![]() View larger version (11K): [in a new window] |
FIG. 4. Host cell damage promotes ETEC adherence. (A) Immunoblot of IPEC-J2 cells after 1 h of treatment with 100 ng/ml LT or after 4 h of infection with E. coli G58-1 or wt or eltAB ETEC at an MOI of 10. Blots were probed with rabbit polyclonal antisera against active caspase 3. (B) ETEC adherence (mean CFU/ml ± SD) following treatment of IPEC-J2 cells with 100 µM camptothecin (campt), with or without 100 µM Ac-DEVD-CHO, for 1 h prior to ETEC infection. (C) ETEC adherence (mean CFU/ml ± SD) to naïve host cells following prestimulation of bacterial inocula with sterile cell-free supernatants derived from donor cells treated with camptothecin, with or without Ac-DEVD-CHO. (D) Relative expression of K88ac-CAT in the presence of supernatants derived from host cells treated with camptothecin, with or without Ac-DEVD-CHO. Data are plotted as relative CAT activities versus that of the bacterial culture additive.
|
eltAB strains (Fig. 4B, gray bars) (P = 0.02), suggesting that the observed phenotype is independent of LT expression. To determine if adherence promotion was dependent upon activation of host caspases, we cotreated cells with camptothecin and Ac-DEVD-CHO, an inhibitor of caspase 3-dependent pathways (39). Treatment of cells with Ac-DEVD-CHO restored subsequent bacterial adherence to near basal levels (Fig. 4B, black bars). These data indicate that inducing apoptosis in IPEC-J2 cells is sufficient to promote subsequent ETEC adherence and that this phenomenon may require the activity of caspase 3 and/or the downstream effectors of this enzyme.
Since chemical induction of apoptosis increased ETEC adherence, we also tested the hypothesis that ETEC might sense a factor secreted from apoptotic cells to upregulate processes associated with adherence to host cells. We treated IPEC-J2 cells with camptothecin, with or without Ac-DEVD-CHO, obtained and filtered the supernatants from these donor cells, and then added these supernatants to log-phase ETEC cultures. After 2 h of incubation, these ETEC inocula were used in bacterial adherence assays on naïve host cells.
Both the wt and
eltAB ETEC strains incubated with supernatants from apoptotic IPEC-J2 cells were enhanced in their subsequent adherence to naïve cells (Fig. 4C, gray bars) (P = 0.02). Cotreatment of donor cells with camptothecin and Ac-DEVD-CHO abolished the adherence-promoting ability of these supernatants (Fig. 4C, black bars). These data raise the possibility that a factor released from host cells following the induction of caspase 3-dependent apoptotic pathways may play a role in regulating gene expression of pathways associated with ETEC adherence. We did not observe an increase in the binding of heat-killed ETEC to apoptotic host cells (data not shown).
To determine if ETEC gene expression was altered in the presence of supernatants from apoptotic IPEC-J2 cells, we measured the transcriptional activity of the regulatory region upstream of the K88ac operon by constructing a fusion to CAT and performing CAT activity assays with ETEC 2534-86 grown in CFA medium supplemented with supernatants derived from IPEC-J2 cells that had been treated with camptothecin, with or without Ac-DEVD-CHO. Notably, transfer of supernatants (3% [vol/vol]) from IPEC-J2 cells treated with camptothecin (Fig. 4D, gray bars), but not those treated with camptothecin plus Ac-DEVD-CHO (Fig. 4D, black bars), resulted in a significant increase in CAT activity.
Concluding remarks. We have described the preliminary characterization of changes to intestinal cell pathways associated with apoptosis induced by porcine ETEC isolates. ETEC infection, independent of LT, rapidly induces the loss of plasma membrane asymmetry (as measured by annexin V staining) and results in a significant reduction in host metabolic activity (as measured by calcein fluorescence). We found no evidence for host cell DNA fragmentation, in agreement with earlier studies of ETEC infection of J774 macrophages (22), despite our observation of host caspase 3 activation. In contrast to the ability of purified OMVs to stimulate PS exposure, bacterial binding was necessary to reduce calcein fluorescence. While it is likely that this intriguing phenotype is due to reduced intracellular esterase activity, it is also possible that activation of the multidrug resistance transporter (17) or a depletion of intracellular ATP associated with epithelial hyperpermeability (29) might also contribute to these observations.
We did not observe a role for guanylin in inducing apoptosis of IPEC-J2 cells. Others have examined the GC-C receptor, which is activated by ST (27). The addition of exogenous guanylin causes apoptosis in T84 cells (26), and the absence of GC-C in a mouse model of intestinal neoplasia results in increased apoptosis (27). However, other studies have shown that ST causes a delay in cell cycle progression in the absence of apoptosis (34).
It is remarkable that both inducing apoptosis in IPEC-J2 cells and the transfer of apoptotic cell supernatants to ETEC promote subsequent bacterial adherence. Invasive enteric pathogens induce apoptosis in human colon epithelial cells, but with a significant delay (12 to 18 h) (22) compared to the time in our studies. While apoptosis may provide the host with a mechanism to delete damaged epithelial cells (22), it may also benefit pathogens by allowing more time for adaptation to host defenses and by promoting penetration of the protective glycocalyx (28) and sampling of limited receptor epitopes (20). Our observation that ETEC may promote changes in host cells typically associated with the initial but not later stages of apoptosis raises the intriguing possibility that ETEC may modulate epithelial cell viability to promote its adherence and dissemination.
This work was supported by a grant to P.R.H. from the South Dakota Agricultural Experiment Station (SD00H177-06IHG) and was conducted in part using the South Dakota State University Functional Genomics Core Facility, which receives support from the National Science Foundation/EPSCoR grant 0091948 and from the State of South Dakota.
Published ahead of print on 20 October 2008. ![]()
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»